Skip to main content
Equibles

VESTOR CAPITAL, LLC

Position in REPL — Replimune Group, Inc.

CIK 1132699 CHICAGO, IL
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Jul 28, 2026
Position Value
$6,165
+$6,122 QoQ
Shares Held
557
+39.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#171
of 199 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VESTOR CAPITAL, LLC holds $261,212,724 across 7 Biotechnology names. REPL ranks #6 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 KRYS
Krystal Biotech, Inc.
 700,914 $260,508,706
2 IBRX
ImmunityBio, Inc.
 44,835 $392,530
3 RPRX
Royalty Pharma plc
 4,400 $246,708
4 TWST
Twist Bioscience Corp
 413 $42,489
5 TGTX
Tg Therapeutics, Inc.
 285 $15,657
6 REPL
Replimune Group, Inc.
This page 		557 $6,165
7 JUNS
Jupiter Neurosciences, Inc.
 29 $469

All Filings in REPL

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,165 557
2025-12-31 $43 400